
Obalon Therapeutics, Inc. OBLN
Obalon Therapeutics, Inc. General and Administrative Expenses 2011-2026 | OBLN
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Obalon Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 8.78 M | 16.7 M | 29.9 M | 28.8 M | 10.2 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29.9 M | 8.78 M | 18.9 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | ||
|
AdaptHealth Corp.
AHCO
|
382 M | $ 12.86 | -1.72 % | $ 1.74 B | ||
|
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | ||
|
Electromed
ELMD
|
39.3 M | $ 25.1 | -0.59 % | $ 212 M | ||
|
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.36 | 1.46 % | $ 126 M | ||
|
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | ||
|
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | ||
|
BioSig Technologies
BSGM
|
67.5 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
16.5 M | $ 10.57 | 2.2 % | $ 299 M | ||
|
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
35.6 M | $ 0.63 | -1.29 % | $ 39.2 M | ||
|
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | ||
|
Helius Medical Technologies
HSDT
|
9.27 M | $ 2.0 | 1.01 % | $ 1.22 M | ||
|
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | ||
|
IRIDEX Corporation
IRIX
|
7.73 M | $ 1.09 | 5.9 % | $ 18.5 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
54.3 M | - | - | $ 10.2 M | ||
|
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
120 M | $ 14.76 | 0.82 % | $ 346 M | ||
|
Butterfly Network
BFLY
|
39.8 M | $ 4.28 | -13.01 % | $ 906 M | ||
|
Second Sight Medical Products
EYES
|
1.11 M | - | -0.97 % | $ 54.4 M | ||
|
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | ||
|
LivaNova PLC
LIVN
|
549 M | $ 58.53 | -0.66 % | $ 3.19 B | ||
|
GBS
GBS
|
8.88 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
1.18 B | $ 88.23 | 0.49 % | $ 11.9 B | ||
|
Delcath Systems
DCTH
|
43.5 M | $ 10.25 | 0.39 % | $ 367 M | ||
|
Insulet Corporation
PODD
|
1.16 B | $ 169.75 | 6.08 % | $ 11.9 B | ||
|
CONMED Corporation
CNMD
|
132 M | $ 38.59 | 7.31 % | $ 1.2 B | ||
|
Inspire Medical Systems
INSP
|
625 M | $ 53.41 | - | $ 1.57 B | ||
|
Sintx Technologies
SINT
|
6.2 M | $ 2.0 | 0.5 % | $ 5.55 M | ||
|
Integer Holdings Corporation
ITGR
|
212 M | $ 83.01 | -0.79 % | $ 2.88 B | ||
|
Edwards Lifesciences Corporation
EW
|
2.09 B | $ 80.96 | -0.32 % | $ 47.3 B | ||
|
Invacare Corporation
IVC
|
227 M | - | - | $ 24.7 M | ||
|
Stryker Corporation
SYK
|
8.65 B | $ 314.5 | -0.2 % | $ 120 B | ||
|
Tactile Systems Technology
TCMD
|
88.7 M | $ 22.53 | 0.13 % | $ 515 M | ||
|
TELA Bio
TELA
|
15.7 M | $ 0.84 | -1.79 % | $ 39.4 M | ||
|
TransMedics Group
TMDX
|
185 M | $ 98.83 | 0.26 % | $ 3.36 B | ||
|
Tandem Diabetes Care
TNDM
|
445 M | $ 18.77 | 3.33 % | $ 1.28 B | ||
|
LENSAR
LNSR
|
45.2 M | $ 5.38 | -0.19 % | $ 64.3 M | ||
|
Pulmonx Corporation
LUNG
|
101 M | $ 1.25 | 4.17 % | $ 50.9 M |